Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|September 29, 2009
MicroRNAs and future therapeutic applications in cancerP Casalini, M V IorioThe Journal of Biological Chemistry|March 30, 2001
Role of p53 in HER2-induced proliferation or apoptosisP Casalini, L Botta, S MenardBritish Journal of Cancer|April 3, 2003
Role of hormonal risk factors in HER2-positive breast carcinomasA Balsari, P Casalini, R Bufalino, et al.Cellular and Molecular Life Sciences : CMLS|December 8, 2004
Role of HER2/neu in tumor progression and therapyS Ménard, P Casalini, M Campiglio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancerS Ménard, P Casalini, M Campiglio, et al.Breast Cancer Research and Treatment|August 6, 2002
Ductal carcinoma in situ of the breast: a new phenotype classification system and its relation to prognosisF Wärnberg, P Casalini, H Nordgren, et al.Schweizerische Medizinische Wochenschrift|November 9, 1985
[Intracoronary electrocardiography during transluminal coronary angioplasty]B Meier, J P Killisch, J J Adatte, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 18, 1997
Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalizationP Casalini, E Luison, S Ménard, et al.FEBS Letters|March 7, 1998
Heregulin beta1 induces the down regulation and the ubiquitin-proteasome degradation pathway of p185HER2 oncoproteinA Magnifico, E Tagliabue, E Ardini, et al.Cancer Research|May 1, 1994
Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killingL R Coney, D Mezzanzanica, D Sanborn, et al.Pageof 4